CordenPharma Small Molecules Platform
Products
Information
Full-Service Partner of Choice from Advanced Intermediates to Drug ProductsIntegrated network of cGMP facilities across Europe and US1,200 m3 of volumetric capacity in 20 L - 28,000 L reactors with various materials of constructionClinical (Phase I-III) and ongoing commercial supply to multiple markets around the world (including US, Europe and Japan)Kilo to Multi-ton production volumes per annumProcess development capabilities (including flow / continuous manufacturing)All sites FDA and EMEA approved facilities with long history of successful regulatory and customer auditsStrong EHS programs in place at sites
Main Categories
APIs (Active Pharmaceutical Ingredients)Custom ManufacturingIntermediates, Fine and Specialty Chemicals
All Categories
Advanced IntermediatesAPI Contract ManufacturingAPIs (Active Pharmaceutical Ingredients)Custom ManufacturingIntermediates, Fine and Specialty Chemicals
Distribution areas
OceaniaNorth America (USA, Canada)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied from
United States
